Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Medisure Laboratories Pakistan Pvt Ltd

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer with sterile and non-sterile manufacturing operations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date21 Oct 2025Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Medisure Laboratories Pakistan (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
A-115, S.I.T.E., Super Highway, Karachi, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000503 Medisure Laboratories Pakistan (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000503 122 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx123public portfolio records represented
REG113unique registrations represented
IDX120indexed MedInfoBase presentations
SRC3additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR120current validated price records
G56generic molecules in indexed catalogue
DF9dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage93%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMedisure Laboratories Pakistan Pvt LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 24 Sep 2026Anti-infectives63 · 53%CNS & mental health23 · 19%Gastrointestinal & hepatology11 · 9%Cardiovascular8 · 7%Hematology & thrombosis7 · 6%Endocrine & metabolic2 · 2%Pain & musculoskeletal2 · 2%Other therapeutic areas4 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMedisure Laboratories Pakistan Pvt LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 24 Sep 2026120presentationsTablet60 · 50%Injection27 · 23%Capsule10 · 8%Cream6 · 5%Infusion6 · 5%Suspension5 · 4%Other forms6 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMedisure Laboratories Pakistan Pvt LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 24 Sep 2026111comparable productsBelow peer median93 · 84%Near peer median11 · 10%Above peer median7 · 6%Company median price position-20.0%Lowest-price equivalents14Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMedisure Laboratories Pakistan Pvt LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,40 shared71% overlapMediate Pharmaceutical Pvt Ltd39 shared70% overlapNeutro Pharma (Pvt.) Ltd.,37 shared66% overlapZafa Pharmaceutical Laboratories (P…35 shared63% overlapBio-Labs(Pvt) Ltd35 shared63% overlapEpharm Laboratories35 shared63% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives63 products · 53%
CNS & mental health23 products · 19%
Gastrointestinal & hepatology11 products · 9%
Cardiovascular8 products · 7%
Hematology & thrombosis7 products · 6%
Endocrine & metabolic2 products · 2%
Pain & musculoskeletal2 products · 2%
Oncology & immunology2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins21 products · 18%
Antiepileptics13 products · 11%
Antipsychotics8 products · 7%
Fluoroquinolone antibacterials7 products · 6%
Macrolide antibacterials7 products · 6%
Antimalarials6 products · 5%
Antiemetics4 products · 3%
Antifungals4 products · 3%
Formulation footprint

Dosage forms

Tablet60 products
Injection27 products
Capsule10 products
Cream6 products
Infusion6 products
Suspension5 products
Solution3 products
Drops2 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CefsureCeftriaxone 10presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 TamlevLevetiracetam 7presentations 100 mg/mL, 250 mg, 500 mg/5 mL, 750 mg · Solution, Tablet, Injection #3 AmesureCiprofloxacin 4presentations 200 mg/100 mL, 250 mg, 500 mg, 750 mg · Infusion, Tablet #4 ClarocinClarithromycin 4presentations 125 mg/5 mL, 250 mg, 500 mg · Drops, Tablet, Infusion #5 QuopineQuetiapine 4presentations 100 mg, 200 mg, 25 mg, 300 mg · Tablet #6 SuresefCefotaxime 4presentations 1 g, 2 g, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median9384% of comparable products
Near market median11within ±5% of median
Above market median76% of comparable products
Lowest-price equivalents14ties included
Company median price position -20.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Ylenol 500 mgParacetamol · Tablet · 10 x 10's PKR 0.80/tablet-78.1% vs market median Penicillamine D-Penicillamine … 250 mgPenicillamine · Tablet · 10's PKR 23.22/tablet-76.7% vs market median Lifsave 0.5 mgNitroglycerin · Tablet · 3 x 10's PKR 0.47/tablet-63.5% vs market median Clarocin 500 mgClarithromycin · IV infusion · 1's PKR 123.85/vial/unit-60.5% vs market median Biofloxacin 400 mgMoxifloxacin · Tablet · 1 x 5's PKR 77.41/tablet-58.0% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 40shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 39shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 37shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 35shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 35shared generics Epharm Laboratories144 products · 67 generics 35shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers110Distinct registrations among indexed, published, presentation-validated products only
Verified price observations120
Products with a verified price120
Products with multiple price observations0
Source records with multiple versions117
Latest portfolio source check22 Sep 2026
Latest effective price date21 Oct 2025
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

113 unique registration(s) · 120 indexed presentation(s) · 3 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Mal-Anx Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 055597 PKR 495.39 PKR 30.96/tablet 22% below median
Mal-Anx Artemether 40 mg Tablet 8's 061446 PKR 408.70 PKR 51.09/tablet 21% below median
Mal-Anx Artemether 80 mg/mL Injection 6's * 1ml Ampoule 073482 PKR 928.86 — No comparator
Malanx DS Plus Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 070724 PKR 511.61 PKR 85.27/tablet 22% below median
Malanx DS Plus Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 070724 PKR 340.58 PKR 85.15/tablet 22% below median
Malprate Sodium valproate 200 mg Tablet 100's 029254 PKR 387.03 PKR 3.87/tablet 16% below median
Malprate-D Valproic acid 250 mg Tablet 10 x 10's 032270 PKR 553.84 PKR 5.54/tablet 14% below median
Malprate-D Valproic acid 500 mg Tablet 10 x 10's 032271 PKR 954.90 PKR 9.55/tablet Near median
Meditrozo Letrozole 2.5 mg Tablet 30's 110009 PKR 9,288.57 PKR 309.62/tablet 24% below median
Meditrozo Letrozole 2.5 mg Tablet 10's 110009 PKR 3,096.19 PKR 309.62/tablet 24% below median
Mezole Metronidazole 5 mg/mL (500 mg/100 mL) IV infusion 1*100ml Vial` 073519 PKR 77.41 — No comparator
Mezole Metronidazole (Benzoate) 5 mg IV infusion 1*100ml Vial` 073519 PKR 77.41 — No comparator
Miconaz Miconazole 2 % Cream 10gm 032810 PKR 66.57 PKR 6.66/g 13% below median
Miosil Amlodipine 5 mg Tablet 2 x 10's 032640 PKR 162.55 PKR 8.13/tablet 25% below median
Miosil Amlodipine 10 mg Tablet 2 x 10's 032641 PKR 308.07 PKR 15.40/tablet 13% below median
Ondace Ondansetron 8 mg Tablet 10's 083002 PKR 1,331.36 PKR 133.14/tablet 20% below median
Ondace Ondansetron 8 mg/4 mL Injection 4ml 104346 PKR 800.36 PKR 200.09/mL 20% below median
Ondace Ondansetron 4 mg Tablet 10's 104347 PKR 798.82 PKR 79.88/tablet 14% below median
Onyfine Terbinafine 1 % Cream 10gm 032811 PKR 260.07 PKR 26.01/g 12% below median
Osesure Oseltamivir 75 mg Capsule 10's 105567 PKR 1,161.07 PKR 116.11/capsule Near median
Patla Clopidogrel 75 mg Tablet 1 x 10's 039363 PKR 216.73 PKR 21.67/tablet 20% below median
Penicillamine D-Penicillamine … Penicillamine 250 mg Tablet 10's 083907 PKR 232.22 PKR 23.22/tablet 77% below median
Phage Metformin 500 mg Tablet 100's 029251 PKR 175.06 PKR 1.75/tablet 36% below median
Quopine Quetiapine 300 mg Tablet 10's 050355 PKR 954.90 PKR 95.49/tablet 30% below median
Quopine Quetiapine 100 mg Tablet 10's 050773 PKR 477.45 PKR 47.75/tablet 36% below median
Quopine Quetiapine 200 mg Tablet 10's 050774 PKR 716.17 PKR 71.62/tablet 23% below median
Quopine Quetiapine 25 mg Tablet 30's 053453 PKR 477.45 PKR 15.92/tablet 24% below median
Radicon Ranitidine 150 mg Tablet 10's 029253 PKR 100.62 PKR 10.06/tablet 10% below median
Rozax Fluoxetine 20 mg Capsule 10's 039088 PKR 100.62 PKR 10.06/capsule 23% below median
Rozax Fluoxetine 20 mg Capsule 20's 039089 PKR 191.96 PKR 9.60/capsule 27% below median
Salicard Acetylsalicylic acid (Aspirin) 150 mg Tablet 10 x 10's 029240 PKR 159.15 PKR 1.59/tablet 37% below median
Salicard Acetylsalicylic acid (Aspirin) 75 mg Tablet 100's 029255 PKR 135.28 PKR 1.35/tablet 34% below median
Soothe Silver sulfadiazine 10 mg/g (1% w/w) Cream 20gm 034063 PKR 57.29 PKR 2.86/g No comparator
Suresef Cefotaxime 2 g Injection 1's 092637 PKR 360.71 PKR 360.71/vial/unit 21% below median
Suresef Cefotaxime 1 g Injection 1's 092638 PKR 239.67 PKR 239.67/vial/unit 16% below median
Suresef Cefotaxime 500 mg Injection 1's 092639 PKR 133.26 PKR 133.26/vial/unit 16% below median
Suresef Cefotaxime 250 mg Injection 1's 092640 PKR 88.42 PKR 88.42/vial/unit 16% below median
Surexime Cefixime 100 mg/5 mL Suspension 30ml 092826 PKR 262.59 PKR 8.75/mL 17% below median
Surexime Cefixime 400 mg Capsule 5's 092827 PKR 472.08 PKR 94.42/capsule 16% below median
Surexime Cefixime 200 mg/5 mL Suspension 30ml 097122 PKR 322.39 PKR 10.75/mL 20% below median
Surexime Cefixime 200 mg Capsule 1*5's 100249 PKR 301.88 PKR 60.38/capsule Near median
Tamlev Levetiracetam 250 mg Tablet 30's 061714 PKR 1,252.52 PKR 41.75/tablet 24% below median
Tamlev Levetiracetam 750 mg Tablet 30's 067559 PKR 2,013.68 PKR 67.12/tablet 49% below median
Tamlev Levetiracetam 750 mg Tablet 30's 067560 PKR 2,769.21 PKR 92.31/tablet 30% below median
Tamlev Levetiracetam 100 mg/mL Oral solution 60ml 081613 PKR 572.94 PKR 9.55/mL 30% below median
Tamlev Levetiracetam 100 mg/mL Oral solution 120ml 081613 PKR 1,145.88 PKR 9.55/mL 30% below median
Tamlev Levetiracetam 100 mg/mL Oral solution 30ml 081613 PKR 302.38 PKR 10.08/mL 26% below median
Tamlev Levetiracetam 500 mg/5 mL Injection 5ml*10's 089267 PKR 4,499.17 — No comparator
Tobarin Tobramycin 0.3% (3 mg/mL) Eye drops 5ml * 1's 075897 PKR 119.37 — No comparator
TrankiliumSource observed — 500 mg Injection 5ml * 10's 076193Official source ↗ No indexed price — —
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Medisure Laboratories Pakistan Pvt Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.